Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Zolpidem Orodispersible Tablet in Healthy Subjects
NCT02607696Phase 1Withdrawn
- Sponsor
- Biolab Farmacêutica
- Start
- May 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of zolpidem in Insomnia (2 arms), sponsored by Biolab Farmacêutica. Primary endpoints: Area under the curve(0-last) at 24 hours, Area under the curve(0-all) at 24 hours and 7 more. Planned start May 2016; status: withdrawn.
02
Drugs
zolpidem
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02607696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607696.